Tel Revelol 40/50

Tel Revelol 40/50 contains Telmisartan (40mg) + Metoprolol Succinate (50mg). Prescription required.

Treatment of hypertension (high blood pressure), especially when single-drug therapy is insufficient; helps reduce risk of cardiovascular events associated with uncontrolled BP.

Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by blocking angiotensin II, lowering blood pressure. Metoprolol succinate is a cardioselective beta-blocker (ER) that reduces heart rate and cardiac output and suppresses renin release, further lowering blood pressure and reducing cardiac workload.

Take by mouth as prescribed, usually once daily at the same time each day. Swallow the tablet whole (do not crush/chew as it is extended-release). Can be taken with or without food; continue regularly even if you feel well.

Dizziness, tiredness/fatigue, headache, slow heart rate (bradycardia), low blood pressure, nausea, diarrhea, cold extremities

Prescription medicine. May cause dizziness—avoid driving until you know its effects. Monitor blood pressure and pulse regularly. Do not stop metoprolol suddenly (risk of angina/heart attack/arrhythmia); taper only under medical supervision. Use with caution in asthma/COPD (may worsen bronchospasm), diabetes (can mask hypoglycemia symptoms), thyroid disorders, peripheral vascular disease, kidney or liver impairment, and in elderly. ARBs like telmisartan can cause increased potassium—avoid potassium supplements/salt substitutes unless advised; monitor serum potassium and kidney function. Contraindicated in pregnancy; avoid in bilateral renal artery stenosis. Seek care for severe dizziness/fainting, very slow pulse, breathing difficulty, swelling of face/lips, or reduced urine output.

Other antihypertensives (additive hypotension), diuretics (enhanced BP drop/dehydration), potassium supplements/salt substitutes and potassium-sparing diuretics (hyperkalemia), NSAIDs (reduced antihypertensive effect and possible kidney injury), lithium (increased lithium levels/toxicity), digoxin (may increase levels—monitor), insulin/oral antidiabetics (beta-blocker may mask hypoglycemia), clonidine (rebound hypertension if withdrawn improperly), verapamil/diltiazem/amiodarone and other rate-lowering drugs (bradycardia/heart block), alcohol (enhanced dizziness)

Store below 25°C in a dry place, protected from light and moisture. Keep in original strip/blister. Keep out of reach of children.

Telma-Beta 40/50 Tablet, Telsar Beta 40/50 Tablet, Cresar Beta 40/50 Tablet, Telmikind Beta 40/50 Tablet, Tazloc Beta 40/50 Tablet